info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Europe Insulin Pens Market Research Report Information By Product (Disposable Insulin Pens, and Cartridges in Reusable Pens) –and Europe Market Forecast Till 2032


ID: MRFR/HC/16257-HCR | 128 Pages | Author: Rahul Gotadki| October 2024

Europe Insulin Pens Market Overview


The Europe's insulin pens market size was valued at USD 2.5 billion in 2022 and is anticipated to expand from USD 2.55 Billion in 2023 to USD 2.98 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 2.00% during the forecast period (2024 - 2032). The increasing population of diabetic patients, the increase in government expenditure for diabetic patients, and the launch of new products by prominent participants are major market drivers driving the insulin pens market in Europe.


Europe Insulin Pens Market Overview


Source: Secondary Research, MRFR Database, Primary Research, and Analyst Review


Insulin Pens Market Trends



  • Increase in the number of people who have diabetes drives market growth.


The European insulin Pens market CAGR is expanding due to an increase in the number of people with diabetes. A massive section of the global population lives unhealthy lifestyles and drinks extensive amounts of carbohydrates in their diets, which can raise their sugar levels in the bloodstream and the chance of diabetes difficulties such as eyesight damage, nerve damage, kidney disease, retinopathy, neuropathy, and other chronic diseases. A rising number of diabetic patients worldwide is driving the need for efficient glucose monitoring and smart insulin pens as they help blood sugar penetrate the body's cells so it can be utilized for energy, thus keeping glucose levels in check. An expanding number of diabetic patients across the globe has led to an increase in healthcare expenditures, resulting in an expansion in demand for smart insulin pens for glucose control.


Furthermore, the increasing geriatric population, increasing prevalence of diabetes type 2 disorder, and launches of new products by key market players, as well as strategies such as mergers and acquisitions, are expected to drive the insulin pens market revenue over the forecast period. For instance, on February 23, 2023, Glooko, a U.S.-based software company, announced a global collaboration with Sanofi, a France-based pharmaceutical company, to integrate SoloSmart with the Glooko platform. SoloSmart is a single-piece add-on connected device intended for usage with SoloStar and DoubleStar insulin injection pens, which records the insulin dose, date, and time of injection and permits the visualization of the data in the Glooko app that patients can share with healthcare professionals for connected care in diabetes management.


Insulin Pens Market Segment Insights


Insulin Pens Product Insights


The European insulin pens market segmentation, based on the product, includes Disposable Insulin Pens and Cartridges in Reusable Pens. The cartridges in the reusable pens segment dominated the market due to the emphasis on user convenience and sustainability. Cartridges allow efficient insulin delivery, reduce medication wastage, and facilitate cost-effective, eco-friendly practices. The shift towards reusable pens with cartridge systems aligns with the region's focus on patient-centric healthcare solutions, offering improved insulin management options for individuals with diabetes. This trend supports the overall growth of the insulin pens market in Europe, reflecting advancements in diabetes care and a commitment to enhancing the patient experience.


Figure 1: Europe Insulin Pens Market, by Product, 2023 & 2032 (USD Billion)


Europe Insulin Pens Market, by Product, 2022 & 2032


Source: Secondary Research, MRFR Database, Primary Research, and Analyst Review


Insulin Pens Country Insights


The European insulin pens market thrives due to the growing prevalence of diabetes and an aging population, which fuels the demand for convenient and efficient insulin delivery methods. Technological advancements in insulin pen devices, offering user-friendly features and precise dosage control, contribute to market growth. Increased awareness of diabetes management and the preference for self-administration among patients drive the adoption of insulin pens. Favorable reimbursement policies and healthcare initiatives further support market expansion. The shift from traditional insulin delivery methods to pens reflects a growing emphasis on patient convenience and improved adherence, positioning the European insulin pens market for continuous advancement and innovation.


Figure 2: EUROPE INSULIN PENS MARKET SHARE BY REGION 2023 (USD Billion)


EUROPE INSULIN PENS MARKET SHARE BY REGION 2022


Source: Secondary Research, MRFR Database, Primary Research, and Analyst Review


Insulin Pens Prominent Market Players & Competitive Insights


Leading market participants invest heavily in research and development to extend their product lines, allowing the insulin pens market to grow even more. Market participants are also undertaking numerous strategic activities to extend their footprint, with significant market outcomes including new product expansions, contractual agreements, mergers and acquisitions, more elevated investments, and collaboration with other organizations. The insulin pens industry must offer cost-effective items to enhance and survive in a more competitive, expanding market climate.


Major participants in the insulin pen market are attempting to expand market needs by investing in research and development operations, including Novo Nordisk, Sanofi, Eli Lilly, Biocon, Medtronic, and Wockhardt.


Key participants in the Insulin Pens Market Include



Insulin Pens Industry Developments


August 2022: Lilly received CE (European Conformity) marking certification for the Tempo Smart Button and plans to begin small-scale pilots in selected countries through partnerships with existing diabetes management ecosystems.


Insulin Pens Market Segmentation


Product Outlook



  • Disposable Insulin Pens

  • Cartridges in Reusable Pens


Insulin Pens Regional Outlook



  • Europe

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Indonesia

    • Thailand

    • Vietnam

    • Malaysia

    • Singapore

    • Rest of Europe



Report Attribute/Metric Details
Market Size 2022 USD 2.5 Billion
Market Size 2023 USD 2.55 Billion
Market Size 2032 USD 2.98 Billion
Compound Annual Growth Rate (CAGR) 2.00% (2024-2032)
Base Year 2023
Market Forecast Period 2024-2032
Historical Data 2018- 2022
Market Forecast Units Value (USD Billion)
Report Coverage Market Competitive Landscape, Revenue Forecast, Growth Factors, and Trends
Segments Covered Product and Region
Region Covered Europe
Countries Covered Germany, France, UK, Italy, Spain, Sweden, Denmark, Luxembourg, Norway, Austria, and Rest of Europe
Key Companies Profiled Novo Nordisk, Sanofi, Eli Lilly, Biocon, Medtronic, and Wockhardt.
Key Market Opportunities ·       Increase in government expenditure for diabetic patients
Key Market Dynamics ·       Launch of new products by key players


Frequently Asked Questions (FAQ) :

The European insulin pens market size was valued at USD 2.5 Billion in 2022.

The market is expected to extend at a CAGR of 5.80% during the forecast period, 2024-2032.

The prominent players in the insulin pens market are Novo Nordisk, Sanofi, Eli Lilly, Biocon, Medtronic, and Wockhardt.

The cartridges in reusable pens dominated the insulin pens market in 2022.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.